Pacira BioSciences, Inc. Insider Trading for June 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Pacira BioSciences, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Pacira BioSciences, Inc. for June 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 13 2019 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Option Exercise | M | 5.49 | 9,000 | 49,410 | 42,856 | |
| Jun 13 2019 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Option Exercise | M | 1.61 | 15,000 | 24,150 | 44,000 | |
| Jun 13 2019 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Buy | M | 5.49 | 9,000 | 49,410 | 169,231 | 160.2 K to 169.2 K (+5.62 %) |
| Jun 13 2019 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Buy | M | 1.61 | 15,000 | 24,150 | 160,231 | 145.2 K to 160.2 K (+10.33 %) |
| Jun 12 2019 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 44.28 | 2,126 | 94,139 | 10,042 | 12.2 K to 10 K (-17.47 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | WINSTON ROY | Chief Clinical Offi ... | Option Exercise | A | 43.54 | 33,800 | 1,471,652 | 33,800 | |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | WINSTON ROY | Chief Clinical Offi ... | Grant | A | 0.00 | 5,600 | 0 | 22,139 | 16.5 K to 22.1 K (+33.86 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | WINSTON ROY | Chief Clinical Offi ... | Sell | S | 42.91 | 722 | 30,981 | 16,539 | 17.3 K to 16.5 K (-4.18 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | CAO and General Cou ... | Option Exercise | A | 43.54 | 33,800 | 1,471,652 | 33,800 | |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | CAO and General Cou ... | Grant | A | 0.00 | 5,600 | 0 | 25,445 | 19.8 K to 25.4 K (+28.22 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | Williams Kristen Marie | CAO and General Cou ... | Sell | S | 42.91 | 2,529 | 108,519 | 19,845 | 22.4 K to 19.8 K (-11.30 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Option Exercise | A | 43.54 | 142,100 | 6,187,034 | 142,100 | |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Grant | A | 0.00 | 23,700 | 0 | 145,231 | 121.5 K to 145.2 K (+19.50 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | STACK DAVID M | CEO and Chairman | Sell | S | 42.91 | 12,385 | 531,440 | 121,531 | 133.9 K to 121.5 K (-9.25 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | Scranton Richard | Chief Scientific Of ... | Option Exercise | A | 43.54 | 30,000 | 1,306,200 | 30,000 | |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | Scranton Richard | Chief Scientific Of ... | Grant | A | 0.00 | 5,000 | 0 | 16,061 | 11.1 K to 16.1 K (+45.20 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | Scranton Richard | Chief Scientific Of ... | Sell | S | 43.50 | 4,114 | 178,959 | 11,061 | 15.2 K to 11.1 K (-27.11 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | Scranton Richard | Chief Scientific Of ... | Sell | S | 42.66 | 2,852 | 121,666 | 15,175 | 18 K to 15.2 K (-15.82 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | Scranton Richard | Chief Scientific Of ... | Sell | S | 42.91 | 2,074 | 88,995 | 18,027 | 20.1 K to 18 K (-10.32 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | A | 43.54 | 11,200 | 487,648 | 11,200 | |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Grant | A | 0.00 | 1,900 | 0 | 12,168 | 10.3 K to 12.2 K (+18.50 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 42.91 | 967 | 41,494 | 10,268 | 11.2 K to 10.3 K (-8.61 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | Reinhart Charles A. III | Chief Financial Off ... | Option Exercise | A | 43.54 | 26,300 | 1,145,102 | 26,300 | |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | Reinhart Charles A. III | Chief Financial Off ... | Grant | A | 0.00 | 4,400 | 0 | 16,336 | 11.9 K to 16.3 K (+36.86 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | Reinhart Charles A. III | Chief Financial Off ... | Sell | S | 42.91 | 1,106 | 47,458 | 11,936 | 13 K to 11.9 K (-8.48 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Option Exercise | A | 43.54 | 8,437 | 367,347 | 8,437 | |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Grant | A | 0.00 | 4,134 | 0 | 36,953 | 32.8 K to 37 K (+12.60 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | McLoughlin Dennis | Chief Commercial Of ... | Option Exercise | A | 43.54 | 33,800 | 1,471,652 | 33,800 | |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | McLoughlin Dennis | Chief Commercial Of ... | Grant | A | 0.00 | 5,600 | 0 | 19,422 | 13.8 K to 19.4 K (+40.52 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | McLoughlin Dennis | Chief Commercial Of ... | Sell | S | 42.91 | 1,099 | 47,158 | 13,822 | 14.9 K to 13.8 K (-7.37 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | LONGENECKER JOHN P PHD | Director | Option Exercise | A | 43.54 | 8,437 | 367,347 | 8,437 | |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | LONGENECKER JOHN P PHD | Director | Grant | A | 0.00 | 4,134 | 0 | 10,061 | 5.9 K to 10.1 K (+69.75 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | LARANJEIRA CHARLES ANTHONY | SVP, Technical Oper ... | Option Exercise | A | 43.54 | 30,000 | 1,306,200 | 30,000 | |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | LARANJEIRA CHARLES ANTHONY | SVP, Technical Oper ... | Grant | A | 0.00 | 5,000 | 0 | 10,367 | 5.4 K to 10.4 K (+93.16 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | LARANJEIRA CHARLES ANTHONY | SVP, Technical Oper ... | Sell | S | 42.91 | 430 | 18,451 | 5,367 | 5.8 K to 5.4 K (-7.42 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | Kronenfeld Mark A. | Director | Option Exercise | A | 43.54 | 8,437 | 367,347 | 8,437 | |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | Kronenfeld Mark A. | Director | Grant | A | 0.00 | 4,134 | 0 | 14,411 | 10.3 K to 14.4 K (+40.23 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | HASTINGS PAUL J | Director | Option Exercise | A | 43.54 | 8,437 | 367,347 | 8,437 | |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | HASTINGS PAUL J | Director | Grant | A | 0.00 | 4,134 | 0 | 6,881 | 2.7 K to 6.9 K (+150.49 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | HASTINGS PAUL J | Director | Sell | S | 42.66 | 782 | 33,360 | 2,747 | 3.5 K to 2.7 K (-22.16 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | Greenstreet Yvonne | Director | Option Exercise | A | 43.54 | 8,437 | 367,347 | 8,437 | |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | Greenstreet Yvonne | Director | Grant | A | 0.00 | 4,134 | 0 | 9,761 | 5.6 K to 9.8 K (+73.47 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Option Exercise | A | 43.54 | 8,437 | 367,347 | 8,437 | |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Grant | A | 0.00 | 4,134 | 0 | 36,953 | 32.8 K to 37 K (+12.60 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | McLoughlin Dennis | Chief Commercial Of ... | Option Exercise | A | 43.54 | 33,800 | 1,471,652 | 33,800 | |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | McLoughlin Dennis | Chief Commercial Of ... | Grant | A | 0.00 | 5,600 | 0 | 19,422 | 13.8 K to 19.4 K (+40.52 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | McLoughlin Dennis | Chief Commercial Of ... | Sell | S | 42.91 | 1,099 | 47,158 | 13,822 | 14.9 K to 13.8 K (-7.37 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | LONGENECKER JOHN P PHD | Director | Option Exercise | A | 43.54 | 8,437 | 367,347 | 8,437 | |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | LONGENECKER JOHN P PHD | Director | Grant | A | 0.00 | 4,134 | 0 | 10,061 | 5.9 K to 10.1 K (+69.75 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | LARANJEIRA CHARLES ANTHONY | SVP, Technical Oper ... | Option Exercise | A | 43.54 | 30,000 | 1,306,200 | 30,000 | |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | LARANJEIRA CHARLES ANTHONY | SVP, Technical Oper ... | Grant | A | 0.00 | 5,000 | 0 | 10,367 | 5.4 K to 10.4 K (+93.16 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | LARANJEIRA CHARLES ANTHONY | SVP, Technical Oper ... | Sell | S | 42.91 | 430 | 18,451 | 5,367 | 5.8 K to 5.4 K (-7.42 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | Kronenfeld Mark A. | Director | Option Exercise | A | 43.54 | 8,437 | 367,347 | 8,437 | |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | Kronenfeld Mark A. | Director | Grant | A | 0.00 | 4,134 | 0 | 14,411 | 10.3 K to 14.4 K (+40.23 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | HASTINGS PAUL J | Director | Option Exercise | A | 43.54 | 8,437 | 367,347 | 8,437 | |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | HASTINGS PAUL J | Director | Grant | A | 0.00 | 4,134 | 0 | 6,881 | 2.7 K to 6.9 K (+150.49 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | HASTINGS PAUL J | Director | Sell | S | 42.66 | 782 | 33,360 | 2,747 | 3.5 K to 2.7 K (-22.16 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | Greenstreet Yvonne | Director | Option Exercise | A | 43.54 | 8,437 | 367,347 | 8,437 | |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | Greenstreet Yvonne | Director | Grant | A | 0.00 | 4,134 | 0 | 9,761 | 5.6 K to 9.8 K (+73.47 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | Froimson Mark | Director | Option Exercise | A | 43.54 | 8,437 | 367,347 | 8,437 | |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | Froimson Mark | Director | Grant | A | 0.00 | 4,134 | 0 | 5,016 | 882 to 5 K (+468.71 %) |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | Brege Laura | Director | Option Exercise | A | 43.54 | 8,437 | 367,347 | 8,437 | |
| Jun 06 2019 | PCRX | Pacira BioSciences ... | Brege Laura | Director | Grant | A | 0.00 | 4,134 | 0 | 8,761 | 4.6 K to 8.8 K (+89.35 %) |
| Jun 05 2019 | PCRX | Pacira BioSciences ... | Scranton Richard | Chief Scientific Of ... | Option Exercise | M | 10.81 | 12,500 | 135,125 | 0 | |
| Jun 05 2019 | PCRX | Pacira BioSciences ... | Scranton Richard | Chief Scientific Of ... | Option Exercise | M | 10.52 | 3,010 | 31,665 | 0 | |
| Jun 05 2019 | PCRX | Pacira BioSciences ... | Scranton Richard | Chief Scientific Of ... | Sell | S | 43.21 | 15,510 | 670,187 | 20,101 | 35.6 K to 20.1 K (-43.55 %) |
| Jun 05 2019 | PCRX | Pacira BioSciences ... | Scranton Richard | Chief Scientific Of ... | Buy | M | 10.81 | 12,500 | 135,125 | 35,611 | 23.1 K to 35.6 K (+54.09 %) |
| Jun 05 2019 | PCRX | Pacira BioSciences ... | Scranton Richard | Chief Scientific Of ... | Buy | M | 10.52 | 3,010 | 31,665 | 23,111 | 20.1 K to 23.1 K (+14.97 %) |